GENESIS Biomed, a consultancy firm specialising in R&D&I projects in the biomedical sector, stands out as a key player in healthcare innovation. Since its founding in 2017, by Josep Lluís Falcó and Natalia de la Figuera, the company has managed 385 projects for 220 clients, generating €9 million in accumulated turnover. Its holistic approach has driven the creation of more than 50 spin-offs and startups from the academic, scientific and healthcare fields, in addition to closing 21 rounds of financing and mobilising more than €80 million.

Among its achievements, GENESIS Biomed has established itself as a leader in attracting European funds, especially from the Horizon Europe programme and EIT Health Flagship, reaching fourth position in the funding ranking, behind major public institutions. In addition, its investment vehicle GENESIS Tech Transfer Boost, with a fund raised to 1.2 million euros, has made strategic investments in start-ups such as Retina Read Risk, Spinally Medical, Affirma Biotech and Ownmed Innovation. This investment model was previously validated with GENESIS Ventures, which invested €2.5 million in 13 biomedical projects, and is currently in the divestment phase.

In addition, the consultancy firm also acts as a venture builder, helping to set up spin-offs from their initial phase until they achieve their valorisation and effective transfer to the market.

During 2024, GENESIS Biomed has played a proactive role in dynamisation of the healthcare innovation ecosystem. It has participated in more than 20 networking and training events and investment forums such as ASEBIO Investor Day and the 2nd ITEMAS Investment Forum, among others. He has also led training programmes in collaboration with universities and institutions such as the Universidad Autónoma de Madrid, the Vall d’Hebron Research Institute and the Centro de Empresas de Innovación de Navarra.

With a strategic vision aimed at connecting stakeholders in the life sciences sector at a national and international level, GENESIS Biomed reinforces its position as a benchmark in the promotion of innovation and entrepreneurship in healthcare.

Summary of the PR published by the Parc Científic de Barcelona on 12 December 2024

You can access the full article at the following link:

https://www.pcb.ub.edu/en/genesis-biomed-consolidates-its-position-as-a-key-player-in-the-growth-and-revitalisation-of-the-spanish-health-innovation-ecosystem/

Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Intelex Vision closes $7.0 million Serie...

by Inveready Asset Management

Intelex Vision, the pioneering company specialising in AI-driven video...

Photos Stream